Genialis

AI-driven RNA biomarker company improving oncology drug development and precision diagnostics by identifying patients most likely to respond to specific cancer therapies. CEO/co-founder: Rafael Rosengarten, Ph.D. Presented at Keiretsu Forum-MST Encore, June 2026.